About Cyted
Cyted is a company based in Cambridge (United Kingdom) founded in 2018 by Maria O'Donovan, Maria Odonovan, Marcel Gehrung, and Rebecca Fitzgerald.. Cyted has raised $50.44 million across 6 funding rounds from investors including British Business Bank, EQT and Advent Life Sciences. Cyted offers products and services including EndoSign, Pathology Services, and Clinical Research. Cyted operates in a competitive market with competitors including Apollo Endo, Valar Labs, NEOGAP, Azra and Oncora, among others.
- Headquarter Cambridge, United Kingdom
- Founders Maria O'Donovan, Maria Odonovan, Marcel Gehrung, Rebecca Fitzgerald
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cyted Ltd
- Date of Incorporation 23 Jul, 2018
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50.44 M (USD)
in 6 rounds
-
Latest Funding Round
$43.82 M (USD), Series B
Sep 01, 2025
-
Investors
British Business Bank
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cyted
Cyted offers a comprehensive portfolio of products and services, including EndoSign, Pathology Services, and Clinical Research. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Fast test for detecting esophageal pre-cancer and diseases.
Services for analyzing gastrointestinal health samples.
Platform for studying and validating digestive disease diagnostics.
Funding Insights of Cyted
Cyted has successfully raised a total of $50.44M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $43.82 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $43.8M
-
First Round
First Round
(31 Jan 2020)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Series B - Cyted | Valuation | EQT , Advent Life Sciences | |
| Dec, 2020 | Amount | Series A - Cyted | Valuation |
investors |
|
| Oct, 2020 | Amount | Series A - Cyted | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cyted
Cyted has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include British Business Bank, EQT and Advent Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Founded Year | Domain | Location | |
|
Early and mid-stage life science focused VC firm investing in the US and Europe
|
Founded Year | Domain | Location | |
|
Private debt fund and fund of funds focused on startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cyted
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cyted
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cyted Comparisons
Competitors of Cyted
Cyted operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apollo Endo, Valar Labs, NEOGAP, Azra and Oncora, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| domain | founded_year | HQ Location |
AI software for oncology treatment planning is provided to providers.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for cancer treatment are developed using advanced technologies.
|
|
| domain | founded_year | HQ Location |
Oncology workflows are automated through AI and machine learning.
|
|
| domain | founded_year | HQ Location |
AI-based clinical data analysis and decision support tool for oncologists
|
|
| domain | founded_year | HQ Location |
Developer of medical devices and biomarkers to detect various diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cyted
Frequently Asked Questions about Cyted
When was Cyted founded?
Cyted was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Cyted located?
Cyted is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Cyted?
Marcel Gehrung is the current CEO of Cyted. They have also founded this company.
Is Cyted a funded company?
Cyted is a funded company, having raised a total of $50.44M across 6 funding rounds to date. The company's 1st funding round was a Series A of $817.08K, raised on Jan 31, 2020.
What does Cyted do?
Cyted was founded in 2018 in Cambridge, United Kingdom, as a gastrointestinal health company. Non-endoscopic diagnostic technologies are pioneered to identify digestive diseases at early stages. Access to care is expanded through these innovations, with operations centered on improving patient outcomes in the diagnostics sector. Leadership includes co-founders such as Marcel Gehrung as CEO and Rebecca Fitzgerald as CSO.
Who are the top competitors of Cyted?
Cyted's top competitors include Apollo Endo, Valar Labs and PAVmed.
What products or services does Cyted offer?
Cyted offers EndoSign, Pathology Services, and Clinical Research.
Who are Cyted's investors?
Cyted has 5 investors. Key investors include British Business Bank, EQT, Advent Life Sciences, Morningside, and BGF.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.